5th Circ. Won't Revive $219M FCA Suit Against Abbott Labs
The Fifth Circuit on Wednesday refused to revive a $219 million False Claims Act suit by a would-be whistleblower accusing Abbott Laboratories of improperly marketing bile duct stents for veins, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article